Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antisense
Biotech
Sanofi inks $400M biobucks deal for Alloy's antisense platform
Sanofi is paying $27.5 million in upfront and near-term fees to use an antisense platform in the development of a central nervous system drug.
Nick Paul Taylor
Jan 8, 2025 5:08am
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks
Oct 24, 2024 8:55am
Takeda axes Huntington’s pact, freeing Wave to pursue partners
Oct 16, 2024 8:07am
Denali reports new method to get ASOs across blood-brain barrier
Aug 14, 2024 2:00pm
Ionis axes eye disease from targets of Roche-partnered prospect
Aug 1, 2024 8:06am
Lilly pays QurAlis $45M for preclinical ALS, dementia prospect
Jun 3, 2024 5:00am
